Capricor Therapeutics Inc —— 资产负债表 (NASDAQ:CAPR)

Financials

总资产 34.62 M41.33 M50.09 M58.73 M170.48 M355.95 M 负债总额 6.42 M9.96 M38.31 M36.13 M25.02 M50.16 M 权益总额 28.2 M31.37 M11.79 M22.6 M145.46 M305.79 M 负债及股东权益总额 34.62 M41.33 M50.09 M58.73 M170.48 M355.95 M 总债务 318.16 K03.38 M3.38 M—— 净债务 -28.97 M-28.64 M-35.46 M-33.89 M——

新闻

Capricor Therapeutics, Inc. (CAPR) Presents at 2026 MDA Clinical & Scientific Conference - Slideshow (NASDAQ:CAPR) 2026-03-13

Capricor: Moving To 'Buy' Rating As New PDUFA Date Is Set For Deramiocel (NASDAQ:CAPR)

Cantor Fitzgerald财报后重申Capricor股票评级

Cantor Fitzgerald reiterates Capricor stock rating after earnings

Capricor Therapeutics, Inc. (CAPR) Q4 2025 Earnings Call Transcript

Capricor Therapeutics第四季度财报未达每股收益预期

Earnings call transcript: Capricor Therapeutics Q4 2025 misses EPS forecasts

Capricor Therapeutics第四季度业绩不及预期股价下跌

Capricor Therapeutics falls on Q4 earnings miss

FDA恢复deramiocel审查后Capricor财报即将公布

Capricor earnings on deck after FDA resumes deramiocel review

Capricor公布Deramiocel治疗杜氏肌营养不良症试验积极数据